Empress Therapeutics develops novel therapeutics based on co-evolved, human-experienced molecules that play a privileged role in human health.
We call these Co-Evolved Medicines™.
The Empression™ product platform uses artificial intelligence and principles from co-evolution and pharmacology to transform patient data into actionable disease insights and therapeutics.
We apply proprietary advances in AI and machine learning to multi-omic human data to discover novel, disease-specific insights and drug candidates.
We pioneer the use of Co-Evolved MoleculesTM that come with the benefit of having already been tested across billions of human lifetimes.
Our discovery engine focuses the search around biologically-relevant drug candidates.
Join Our Team
Interested in working with us?
Get in touch.